| Dr Francisco J Cano, MD | |
|
59 W Main St, Greenville, PA 16125-2449 | |
| (724) 588-7531 | |
| (724) 588-5914 |
| Full Name | Dr Francisco J Cano |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 43 Years |
| Location | 59 W Main St, Greenville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881660249 | NPI | - | NPPES |
| 0696840 | Medicaid | OH | |
| 1016141500005 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 35-069917 (Ohio) | Secondary |
| 207K00000X | Allergy & Immunology | MD040991E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mh St Joseph Warren Hospital | Warren, OH | Hospital |
| Upmc Horizon | Greenville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Francisco Cano Md Pc | 0042223513 | 2 |
| Francisco Cano Md Pc | 0042223513 | 2 |
News Archive
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Regular exercise, including brisk walking, is associated with a decrease in the incidence of breast cancer in African American women.
The prostates of older mice contain more luminal progenitor cells - cells capable of generating new prostate tissue - than the prostates of younger mice, UCLA researchers have discovered.
› Verified 1 days ago
| Entity Name | Francisco Cano Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208432 PECOS PAC ID: 0042223513 Enrollment ID: O20070509000799 |
News Archive
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Regular exercise, including brisk walking, is associated with a decrease in the incidence of breast cancer in African American women.
The prostates of older mice contain more luminal progenitor cells - cells capable of generating new prostate tissue - than the prostates of younger mice, UCLA researchers have discovered.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Francisco J Cano, MD 59 W Main St, Greenville, PA 16125-2449 Ph: (724) 588-7531 | Dr Francisco J Cano, MD 59 W Main St, Greenville, PA 16125-2449 Ph: (724) 588-7531 |
News Archive
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.
Prof. Thomas Wolbers from the Magdeburg site of the German Center for Neurodegenerative Diseases (DZNE) has been awarded a "Starting Grant" from the European Research Council (ERC) and thus, the support of one of Europe's most prestigious funding programs. Wolbers, who in 2012 was jointly appointed by the Otto-von-Guericke-Universit-t Magdeburg and the DZNE as professor for "Cognitive Ageing", will explore how spatial orientation changes in elderly humans.
Regular exercise, including brisk walking, is associated with a decrease in the incidence of breast cancer in African American women.
The prostates of older mice contain more luminal progenitor cells - cells capable of generating new prostate tissue - than the prostates of younger mice, UCLA researchers have discovered.
› Verified 1 days ago